Earnings History Data for Enanta Pharmaceuticals, Inc. (ENTA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-05-2024	AH		ENTA	Enanta Pharmaceuticals, Inc.	294.28	-1.47	-1.26	-1.79	Enanta Pharma GAAP EPS of -$1.47 misses by $0.17, revenue of $17.05M beats by $0.84M [5/6/2024 4:04 PM]	13.14	-1.46 (-10.00%)	14.60	0.0 (0.00%)	8.08 - 36.04	239,657	120,000	1,171
Enanta Pharma GAAP EPS of -$1.47 misses by $0.17, revenue of $17.05M beats by $0.84M [5/6/2024 4:04 PM]
07-02-2024	AH		ENTA	Enanta Pharmaceuticals, Inc.	261.70	-1.58	-1.09	-1.39	Enanta Pharma GAAP EPS of -$1.58 misses by $0.35, revenue of $18M misses by $3.95M [2/7/2024 4:05 PM]	12.37	0.11 (0.90%)	11.90	-0.36 (-2.94%)	8.08 - 62.06	397,209	180,000	5,778
Enanta Pharma GAAP EPS of -$1.58 misses by $0.35, revenue of $18M misses by $3.95M [2/7/2024 4:05 PM]
20-11-2023	AH		ENTA	Enanta Pharmaceuticals, Inc.	182.97	-1.33	-2.11	-1.27	Enanta Pharma GAAP EPS of -$1.33 beats by $0.82, revenue of $18.93M beats by $1.43M [11/20/2023 4:02 PM]	9.98	1.04 (11.63%)	9.33	0.39 (4.36%)	8.08 - 62.06	495,606	330,000	284
Enanta Pharma GAAP EPS of -$1.33 beats by $0.82, revenue of $18.93M beats by $1.43M [11/20/2023 4:02 PM]
07-08-2023	AH		ENTA	Enanta Pharmaceuticals, Inc.	409.74	-1.86	-2.38	-1.53	Enanta Pharma GAAP EPS of -$1.86 beats by $0.47, revenue of $18.89M beats by $2.15M [8/7/2023 4:02 PM]	18.48	-0.86 (-4.45%)	19.34	0.0 (0.00%)	15.63 - 76.36	364,247	190,000	2,877
Enanta Pharma GAAP EPS of -$1.86 beats by $0.47, revenue of $18.89M beats by $2.15M [8/7/2023 4:02 PM]
08-05-2023	AH	4:00 PM ET (May 8)	ENTA	Enanta Pharmaceuticals, Inc.	758.18	-1.79	-1.91	-1.63	Enanta Pharma GAAP EPS of -$1.79 beats by $0.13, revenue of $17.8M misses by $1.26M [5/8/2023 4:07 PM]	25.50	-8.83 (-25.72%)	24.50	-9.83 (-28.63%)	23.03 - 76.36	851,231	180,000	37,847
Enanta Pharma GAAP EPS of -$1.79 beats by $0.13, revenue of $17.8M misses by $1.26M [5/8/2023 4:07 PM] Enanta Pharma Q2 2023 Earnings Preview [5/8/2023 5:35 PM] Enanta falls 21% as fiscal 2023 Q2 revenue misses [5/8/2023 5:48 PM]
07-02-2023	AH	4:00 PM ET (Feb 7)	ENTA	Enanta Pharmaceuticals, Inc.	1,100	-1.39	-1.52	-1.48	Enanta Pharma GAAP EPS of -$1.39 beats by $0.16, revenue of $23.6M beats by $1.12M [2/7/2023 4:03 PM]	52.90	-1.69 (-3.10%)	54.59	0.0 (0.00%)	37.59 - 79.50	134,995	140,000	3,053
Enanta Pharma GAAP EPS of -$1.39 beats by $0.16, revenue of $23.6M beats by $1.12M [2/7/2023 4:03 PM]
21-11-2022	AH	4:00 PM ET (Nov 21)	ENTA	Enanta Pharmaceuticals	951.00	-1.27	-1.37	0.00	Enanta Pharma GAAP EPS of -$1.27 beats by $0.07, revenue of $20.32M misses by $2.54M [11/21/2022 4:06 PM]	45.39	-1.01 (-2.18%)	46.40	0.0 (0.00%)	37.59 - 92.90	192,422	150,000	2,521
Enanta Pharma GAAP EPS of -$1.27 beats by $0.07, revenue of $20.32M misses by $2.54M [11/21/2022 4:06 PM] Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET [Nov-21-22 04:02PM] Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Lags Revenue Estimates [Nov-21-22 05:15PM] Enanta Pharmaceuticals to Participate in Two Investor Conferences in November [Nov-22-22 07:00AM]
08-08-2022	AH	4:00 PM ET (Aug 8)	ENTA	Enanta Pharmaceuticals, Inc.	1,000.00	-1.53	-1.36	-1.19	Enanta Pharma GAAP EPS of -$1.53 misses by $0.16, revenue of $19.48M misses by $1.25M [8/8/2022 4:10 PM]	67.83	-3.44 (-4.83%)	71.27	0.0 (0.00%)	37.59 - 102.00	206,065	260,000	12,825
Enanta Pharma GAAP EPS of -$1.53 misses by $0.16, revenue of $19.48M misses by $1.25M [8/8/2022 4:10 PM] Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET [Aug-08-22 04:03PM] Enanta Pharmaceuticals Appoints Scott T. Rottinghaus, M.D., as Senior Vice President and Chief Medical Officer [Aug-08-22 04:00PM]
09-05-2022	AH	4:00 PM ET (May 9)	ENTA	Enanta Pharmaceuticals, Inc.	1,220	-1.63	-1.43	-1.09	Enanta Pharma GAAP EPS of -$1.63 misses by $0.20, revenue of $18.72M misses by $1.95M [5/9/2022 4:06 PM]	56.84	3.91 (7.39%)	52.93	0.0 (0.00%)	40.37 - 102.00	189,387	208,018	45,362
Enanta Pharma GAAP EPS of -$1.63 misses by $0.20, revenue of $18.72M misses by $1.95M [5/9/2022 4:06 PM] Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET [May-09-22 04:01PM] Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates [May-09-22 05:45PM] Enanta Pharmaceuticals (ENTA) Q2 2022 Earnings Call Transcript [May-10-22 02:11AM]
08-02-2022	AH	4:00 PM ET (Feb 8)	ENTA	Enanta Pharmaceuticals, Inc.	1,200	-1.48	-1.13	-0.41	Enanta Pharma GAAP EPS of -$1.48 misses by $0.37, revenue of $27.65M beats by $0.28M [2/8/2022 4:03 PM]	64.74	3.56 (5.82%)	63.68	2.50 (4.09%)	40.37 - 102.00	305,911	210,000	1,120
Enanta Pharma GAAP EPS of -$1.48 misses by $0.37, revenue of $27.65M beats by $0.28M [2/8/2022 4:03 PM] Why Enanta Pharmaceuticals (ENTA) Might Surprise This Earnings Season [Feb-07-22 08:56AM] Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET [Feb-08-22 04:01PM] Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates [Feb-08-22 03:25PM] Enanta Pharmaceuticals (ENTA) Q1 2022 Earnings Call Transcript [Feb-09-22 01:00AM]
22-11-2021	AH	4:00 PM ET (Nov 22)	ENTA	Enanta Pharmaceuticals, Inc.	1,870	-1.22	-1.31	-0.55	Enanta Pharma EPS beats by $0.06, misses on revenue [11/22/2021 4:04 PM]	86.51	11.33 (15.07%)	75.18	0.0 (0.00%)	40.32 - 102.00	263,979	200,000	894
Enanta Pharma EPS beats by $0.06, misses on revenue [11/22/2021 4:04 PM] Enanta adds more than a tenth, most in over a year after quarterly results [11/23/2021 3:51 PM] Is a Surprise Coming for Enanta Pharmaceuticals (ENTA) This Earnings Season? [Nov-19-21 08:52AM] 52 Biggest Movers From Friday [Nov-22-21 04:53AM] Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET [Nov-22-21 04:01PM] Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Lags Revenue Estimates [Nov-22-21 05:15PM]
05-08-2021	AH	4:00 PM ET (Aug 5)	ENTA	Enanta Pharmaceuticals, Inc.	870.41	-1.19	-1.41	-0.71	Enanta Pharma EPS beats by $0.16, misses on revenue [8/5/2021 4:02 PM]	44.97	-1.28 (-2.77%)	46.25	0.0 (0.00%)	40.32 - 56.97	191,744	150,000	5,699
Enanta Pharmaceuticals Announces Nomination of Clinical Candidate EDP-235, its Lead Oral Protease Inhibitor Specifically Designed for the Treatment of COVID-19 [Aug-05-21 07:00AM] Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Third Quarter Ended June 30, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET [Aug-05-21 04:01PM] Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Misses Revenue Estimates [Aug-05-21 06:05PM] Enanta Pharmaceuticals, inc (ENTA) Q3 2021 Earnings Call Transcript [Aug-06-21 12:01AM]
06-05-2021	AH	4:00 PM ET (May 6)	ENTA	Enanta Pharmaceuticals, Inc.	1,040	-1.09	-0.94	-0.30	Enanta Pharma EPS misses by $0.12, misses on revenue [5/6/2021 4:06 PM]	48.51	-2.49 (-4.88%)	51.00	0.0 (0.00%)	40.32 - 58.59	120,068	100,000	20,700
Enanta Pharma EPS misses by $0.12, misses on revenue [5/6/2021 4:06 PM] Enanta Pharma shows positive effect in early-stage study for hep B therapy [5/6/2021 4:26 PM] Enanta Pharmaceuticals, Inc. to Host Earnings Call [May-06-21 02:45PM] Enanta Pharmaceuticals Reports Positive Data from Part 2 of its Phase 1b Study of EDP-514 in Chronic Hepatitis B Virus Patients on Treatment with a Nucleoside Reverse Transcriptase Inhibitor [May-06-21 04:01PM] Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET [May-06-21 04:01PM] Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates [May-06-21 05:45PM] Enanta Pharmaceuticals Inc (ENTA) Q2 2021 Earnings Call Transcript [May-07-21 05:01AM] Enanta's EDP-514 Four-Week Treatment Shows Around 10 Time Reduction In Hepatitis B Virus RNA [May-07-21 09:58AM]
08-02-2021	AH	4:00 PM ET (Feb 8)	ENTA	Enanta Pharmaceuticals, Inc.	1,060	-0.41	-0.82	0.65	Enanta Pharma EPS beats by $0.39, beats on revenue [2/8/2021 4:08 PM]	54.69	-0.26 (-0.47%)	54.95	0.0 (0.00%)	38.40 - 58.59	117,001	164,370	2,237
Enanta Pharma EPS beats by $0.39, beats on revenue [2/8/2021 4:08 PM] Enanta Pharmaceuticals, Inc. to Host Earnings Call [Feb-08-21 02:30PM]
23-11-2020	AH	4:00 PM ET (Nov 23)	ENTA	Enanta Pharmaceuticals, Inc.	886.19	-0.55	-0.92	0.44	Enanta Pharma EPS misses by $0.52, misses on revenue [11/23/2020 4:06 PM]	42.82	-0.85 (-1.95%)	41.57	-2.10 (-4.81%)	38.40 - 67.88	273,713	124,740	3,332
Enanta Pharma EPS misses by $0.52, misses on revenue [11/23/2020 4:06 PM]
04-08-2020	AH	4:00 PM ET (Aug 4)	ENTA	Enanta Pharmaceuticals, Inc.	917.20	-0.71	-0.73	0.33	Enanta Pharma EPS beats by $0.26, misses on revenue [8/4/2020 4:05 PM]	45.80	-1.89 (-3.96%)	47.69	0.0 (0.00%)	38.40 - 75.66	69,012	159,082	1,303

06-05-2020	AH		ENTA	Enanta Pharmaceuticals, Inc.	1,020	-0.30	-0.73	0.20		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0